ABT vs NTRP · P/E 25, rev $44.33B vs rev $3.7M
Abbott Laboratories (ABT) versus NextTrip Inc (NTRP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
NextTrip Inc (NTRP) is a travel services company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported NTRP revenue for 2026-02-28 was $3.7M. Net income was -$15.9M. Revenue was up 641.0% from 2025-02-28 to 2026-02-28. NTRP currently screens at market cap $29.4M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. NTRP currently screens at market cap $29.4M.
Not investment advice. Open the ABT and NTRP stock pages for the full models.
Not investment advice.